首页 | 本学科首页   官方微博 | 高级检索  
     

右美托咪定抑制瑞芬太尼诱发痛觉过敏的研究进展
引用本文:张耀贤,张中军. 右美托咪定抑制瑞芬太尼诱发痛觉过敏的研究进展[J]. 广州医药, 2014, 45(1): 83-85
作者姓名:张耀贤  张中军
作者单位:张耀贤 (暨南大学第二临床医学院,深圳市人民医院麻醉科,深圳,518000); 张中军 (暨南大学第二临床医学院,深圳市人民医院麻醉科,深圳,518000);
摘    要:瑞芬太尼作为一种人工合成的超短效阿片类药物,广泛应用于临床麻醉,但持续输注瑞芬太尼可诱发痛觉过敏。右美托咪定是一种高选择性的α2肾上腺素能受体激动剂,具有镇静、抗焦虑和镇痛等作用。近年有研究报道右美托咪定可抑制瑞芬太尼诱发的痛觉过敏,本文将就相关研究进行综述。

关 键 词:右美托咪定  瑞芬太尼  痛觉过敏

Research progress on dexmedetomidine inhibit hyperalgesia induced byremifentanil
Zhang Yaoxian,Zhang Zhongjun. Research progress on dexmedetomidine inhibit hyperalgesia induced byremifentanil[J]. Guangzhou Medical Journal, 2014, 45(1): 83-85
Authors:Zhang Yaoxian  Zhang Zhongjun
Affiliation:.( Department of Anesthesiology, Shenzhen people's hospital, second clinical medical college of Jinan university, Shenzhen 518000, China)
Abstract:Remifentanil is a synthetic ultra-short-effect opioid drugs. It has been widely used in clinical anesthesia. However, a continuous infusion of remifentanil may induce hyperalgesia. Dexmedetomidine is a highly selective α2-ad- renoceptor agonist, providing sedation, antianxi-ety and analgesia. Recent studies have reported dexmedetomidine can inhibit hy- peralgesia induced by remifentanil, the relevant studies were reviewed.
Keywords:Dexmedetomidine  Remifentanil  Hyperalgesia
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号